Yisel M Cantres-Rosario1, Natalia Hernandez, Karla Negron, Juliana Perez-Laspiur, John Leszyk, Scott A Shaffer, Loyda M Meléndez. 1. aUniversity of Puerto Rico, Medical Sciences Campus, Department of Microbiology and Medical Zoology bUniversity of Puerto Rico, Rio Piedras Campus, Department of Biology, San Juan cUniversity of Puerto Rico, Bayamón Campus, Department of Biology, Bayamón dUniversity of Puerto Rico, Medical Sciences Campus, RCMI Translational Proteomics Center, San Juan, Puerto Rico eProteomics and Mass Spectrometry Facility and Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Abstract
OBJECTIVE: HIV-1 infection of macrophages increases cathepsin B secretion and induces neuronal apoptosis, but the molecular mechanism remains unclear. DESIGN: We identified macrophage-secreted cathepsin B protein interactions extracellularly and their contribution to neuronal death in vitro. METHODS: Cathepsin B was immunoprecipitated from monocyte-derived macrophage supernatants after 12 days postinfection. The cathepsin B interactome was identified by label-free tandem mass spectrometry and compared with uninfected supernatants. Proteins identified were validated by western blot. Neurons were exposed to macrophage-conditioned media in presence or absence of antibodies against cathepsin B and interacting proteins. Apoptosis was measured using TUNEL labeling. Immunohistochemistry of postmortem brain tissue samples from healthy, HIV-infected and Alzheimer's disease patients was performed to observe the ex-vivo expression of the proteins identified. RESULTS: Nine proteins co-immunoprecipitated differentially with cathepsin B between uninfected and HIV-infected macrophages. Serum amyloid P component (SAPC)-cathepsin B interaction increased in HIV-infected macrophage supernatants, while matrix metalloprotease 9 (MMP-9)-cathepsin B interaction decreased. Pre-treatment of HIV-infected macrophage-conditioned media with antibodies against cathepsin B and SAPC decreased neuronal apoptosis. The addition of MMP-9 antibodies was not neuro-protective SAPC was overexpressed in postmortem brain tissue from HIV-positive neurocognitive impaired patients compared with HIV positive with normal cognition and healthy controls, although MMP-9 expression was similar in all tissues. CONCLUSION: Inhibiting SAPC-cathepsin B interaction protects against HIV-induced neuronal death and may help to find alternative treatments for HIV-associated neurocognitive disorders.
OBJECTIVE:HIV-1 infection of macrophages increases cathepsin B secretion and induces neuronal apoptosis, but the molecular mechanism remains unclear. DESIGN: We identified macrophage-secreted cathepsin B protein interactions extracellularly and their contribution to neuronal death in vitro. METHODS:Cathepsin B was immunoprecipitated from monocyte-derived macrophage supernatants after 12 days postinfection. The cathepsin B interactome was identified by label-free tandem mass spectrometry and compared with uninfected supernatants. Proteins identified were validated by western blot. Neurons were exposed to macrophage-conditioned media in presence or absence of antibodies against cathepsin B and interacting proteins. Apoptosis was measured using TUNEL labeling. Immunohistochemistry of postmortem brain tissue samples from healthy, HIV-infected and Alzheimer's diseasepatients was performed to observe the ex-vivo expression of the proteins identified. RESULTS: Nine proteins co-immunoprecipitated differentially with cathepsin B between uninfected and HIV-infected macrophages. Serum amyloid P component (SAPC)-cathepsin B interaction increased in HIV-infected macrophage supernatants, while matrix metalloprotease 9 (MMP-9)-cathepsin B interaction decreased. Pre-treatment of HIV-infected macrophage-conditioned media with antibodies against cathepsin B and SAPC decreased neuronal apoptosis. The addition of MMP-9 antibodies was not neuro-protective SAPC was overexpressed in postmortem brain tissue from HIV-positive neurocognitive impairedpatients compared with HIV positive with normal cognition and healthy controls, although MMP-9 expression was similar in all tissues. CONCLUSION: Inhibiting SAPC-cathepsin B interaction protects against HIV-induced neuronal death and may help to find alternative treatments for HIV-associated neurocognitive disorders.
Authors: Ke-Jie Yin; John R Cirrito; Ping Yan; Xiaoyan Hu; Qingli Xiao; Xiaoou Pan; Randall Bateman; Haowei Song; Fong-Fu Hsu; John Turk; Jan Xu; Chung Y Hsu; Jason C Mills; David M Holtzman; Jin-Moo Lee Journal: J Neurosci Date: 2006-10-25 Impact factor: 6.167
Authors: Vivian Hook; Thomas Toneff; Matthew Bogyo; Doron Greenbaum; Katalin F Medzihradszky; John Neveu; William Lane; Gregory Hook; Terry Reisine Journal: Biol Chem Date: 2005-09 Impact factor: 3.915
Authors: M B Pepys; J Herbert; W L Hutchinson; G A Tennent; H J Lachmann; J R Gallimore; L B Lovat; T Bartfai; A Alanine; C Hertel; T Hoffmann; R Jakob-Roetne; R D Norcross; J A Kemp; K Yamamura; M Suzuki; G W Taylor; S Murray; D Thompson; A Purvis; S Kolstoe; S P Wood; P N Hawkins Journal: Nature Date: 2002-05-16 Impact factor: 49.962
Authors: Vivian Y H Hook; Mark Kindy; Thomas Reinheckel; Christoph Peters; Gregory Hook Journal: Biochem Biophys Res Commun Date: 2009-06-06 Impact factor: 3.575
Authors: Yisel M Cantres-Rosario; Frances M Acevedo-Mariani; Juliana Pérez-Laspiur; William E Haskins; Marines Plaud; Yadira M Cantres-Rosario; Richard Skolasky; Israel Méndez-Bermúdez; Valerie Wojna; Loyda M Meléndez Journal: PLoS One Date: 2017-07-26 Impact factor: 3.240
Authors: Yisel M Cantres-Rosario; Sarah C Ortiz-Rodríguez; Aemil G Santos-Figueroa; Marines Plaud; Karla Negron; Bianca Cotto; Dianne Langford; Loyda M Melendez Journal: Sci Rep Date: 2019-05-29 Impact factor: 4.379
Authors: Lester J Rosario-Rodríguez; Yamil Gerena; Luis A García-Requena; Luz J Cartagena-Isern; Juan C Cuadrado-Ruiz; Gabriel Borges-Vélez; Loyda M Meléndez Journal: Sci Rep Date: 2022-01-07 Impact factor: 4.379
Authors: Omar Vélez López; Santhi Gorantla; Annabell C Segarra; María C Andino Norat; Manuel Álvarez; Richard L Skolasky; Loyda M Meléndez Journal: J Neuroimmune Pharmacol Date: 2018-10-10 Impact factor: 4.147